Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ibuprofenamine HCl spray vs celecoxib for knee osteoarthritis
CTR20211917Phase 3Completed
- Sponsor
- Tianjin Xinchen Taifeier Pharmaceutical Technology
- Start
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ibuprofenamine hydrochloride in primary osteoarthritis of knee, sponsored by Tianjin Xinchen Taifeier Pharmaceutical Technology. Started Aug 2021; status: completed.
02
Drugs
ibuprofenamine hydrochloride
03
Conditions
primary osteoarthritis of knee
Beyond the preview
Go deeper on CTR20211917.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20211917.